Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study

Background: Heart failure (HF) is one of the mayor contributors to cardiovascular morbidity and mortality in patients with diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated to reduce the risk of hospitalization for HF in patients with type 2 diabetes mellitus (T2D). We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín, Ernesto, López-Aguilera, José, González-Manzanares, Rafael, Anguita, Manuel, Gutiérrez, Guillermo, Luque, Aurora, Paredes, Nick, Oneto, Jesús, Perea, Jorge, Castillo, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867051/
https://www.ncbi.nlm.nih.gov/pubmed/33535424
http://dx.doi.org/10.3390/jcm10030505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867051/
https://www.ncbi.nlm.nih.gov/pubmed/33535424
http://dx.doi.org/10.3390/jcm10030505

Ejemplares similares